Dairy Products With Reduced Sugar and Blood Glucose

NCT ID: NCT04854603

Last Updated: 2023-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2021-09-02

Study Completion Date

2022-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dairy products represent an important food group in human nutrition as a source of calcium, protein, functional fats and low-glycaemic sugar lactose. While traditionally consumed natural milk and yogurt have low sugar content, many flavoured liquid dairy products such as chocolate milk, or fermented products such as yogurt have added sugar. Our recent studies have shown that the partial reduction of added sugar in chocolate milk and yogurt is not associated with any inferior sensory characteristics such as taste and pleasantness compared to their full-sugar counterparts. The current project will investigate whether the liquid dairy products with reduced sugar content (value-added products) have any benefits on blood glucose control in humans.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Blood Glucose, High Metabolic Disease Overweight and Obesity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

CROSSOVER

Primary Study Purpose

PREVENTION

Blinding Strategy

DOUBLE

Participants Investigators
Treatments will be blinded. The Investigator will be blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Chocolate milk with a regular added sugar content

Dairy product with a regular sugar content

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with regular and reduced sugar content and water control.

Chocolate milk with a reduced added sugar content

Dairy product with a reduced sugar content

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with regular and reduced sugar content and water control.

Yogurt with a regular added sugar content

Dairy product with a regular sugar content

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with regular and reduced sugar content and water control.

Yogurt with a reduced added sugar content

Dairy product with a reduced sugar content

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with regular and reduced sugar content and water control.

Energy-free control

Potable water

Group Type EXPERIMENTAL

Food

Intervention Type OTHER

Dairy products with regular and reduced sugar content and water control.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Food

Dairy products with regular and reduced sugar content and water control.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* 19-35 y males and females, non-smokers

Exclusion Criteria

* having any diseases, irregular menses in females, smoking (all types), taking medications known to influence blood glucose control, skipping breakfast, and having emotional, or learning problems that would affect their ability to participate in the study as required. Individuals with known food allergies and lactose intolerance will be also excluded.
Minimum Eligible Age

19 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Mount Saint Vincent University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Bohdan Luhovyy

Associate Professor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Bohdan Luhovyy, PhD

Role: PRINCIPAL_INVESTIGATOR

Mount Saint Vincent University

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mount Saint Vincent University

Halifax, Nova Scotia, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2019-202-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Effect of Lactose on Blood Lipids
NCT04924530 COMPLETED NA